Ian C. Read (at the address on file with Pfizer Inc.)Letter Agreement • December 19th, 2019 • Pfizer Inc • Pharmaceutical preparations • New York
This letter agreement (this “Agreement”) memorializes the discussions and agreement between you and Pfizer Inc. (“Pfizer”, and each of you and Pfizer, a “Party”) concerning your services as a consultant to Pfizer in connection with the spin-off or separation of Upjohn Inc. (“Upjohn”) and the combination of Upjohn and Mylan N.V. (“Mylan”). As of July 29, 2019, Pfizer, Upjohn, Utah Acquisition Sub Inc., Mylan, Mylan I B.V. entered into the Business Combination Agreement (as it may be amended from time to time, the “BCA”), which, upon the Effective Time (as defined in the BCA), will result in the combination of Upjohn and Mylan and the formation of a new corporation (“NewCo”).
